Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Francesca, Morandi"'
Autor:
Francesca Morandi
Publikováno v:
RIVISTA ITALIANA DI DIRITTO DEL TURISMO. :39-42
Autor:
Sabrina Bonomini, Francesca Morandi, Sara Tagliaferri, Marcellina Mangoni, Roberto Sala, Mirca Lazzaretti, Gaetano Donofrio, Nicola Giuliani, Vittorio Rizzoli
Publikováno v:
Cancer Research. 67:7665-7674
Osteoblast impairment occurs within multiple myeloma cell infiltration into the bone marrow. Canonical Wnt signaling activation in osteoprogenitor cells is involved in osteoblast formation through the stabilization of dephosphorylated β-catenin and
Autor:
Francesca Morandi, Monica Crugnola, Cristina Mancini, Mario Pedrazzoni, Vittorio Rizzoli, Mirca Lazzaretti, Simona Colla, Nicola Giuliani, Sabrina Bonomini, Rita Rizzato, Paolo Lunghi
Publikováno v:
Leukemia. 19:2166-2176
Osteopontin (OPN) is a multifunctional bone matrix glycoprotein that is involved in angiogenesis, cell survival and tumor progression. In this study we show that human myeloma cells directly produce OPN and express its major regulating gene Runx2/Cbf
Autor:
Silvia Colucci, Francesca Morandi, Roberto Sala, Mirca Lazzaretti, Mirija Svaldi, Vittorio Rizzoli, Simona Colla, Nicola Giuliani, Maria Grano, Sabrina Bonomini
Publikováno v:
Blood. 106:2472-2483
Decreased bone formation contributes to the development of bone lesions in multiple myeloma (MM) patients. In this study, we have investigated the effects of myeloma cells on osteoblast formation and differentiation and the potential role of the crit
Autor:
Vittorio Rizzoli, Lori A. Ehrlich, Sun Jin Choi, Simona Colla, Irene M. Ghobrial, G. David Roodman, Francesca Morandi, Ho Yeon Chung, Nicola Giuliani
Publikováno v:
Blood. 106:1407-1414
Bone destruction in multiple myeloma is characterized both by markedly increased osteoclastic bone destruction and severely impaired osteoblast activity. We reported that interleukin-3 (IL-3) levels are increased in bone marrow plasma of myeloma pati
Publikováno v:
Leukemia & Lymphoma. 46:29-33
Multiple myeloma (MM) is a plasma cell malignancy characterized by an increase of the bone marrow angiogenesis. Angiopoietin-1 (Ang-1) is a critical factor in the regulation of physiological and pathological vessel formation that acts by binding to a
Autor:
Isabel De Celis, Magda Hojden, Elena Sabbatini, Luisa Craviotto, Francesca Morandi, Monica Crugnola, Gabriella Sammarelli, Vittorio Rizzoli, Simona Colla, Nicola Giuliani, Stefano Ascani, Sabrina Bonomini, Cecilia Caramatti
Publikováno v:
European Journal of Haematology. 72:361-365
In this study, we describe an extremely rare case of co-existence of a Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. A morphological, immu
Autor:
Sabrina Bonomini, Nicola Giuliani, Antonio Bonati, Paolo Lunghi, Vittorio Rizzoli, Francesca Morandi, Simona Colla, Magda Hojden
Publikováno v:
Leukemia. 18:628-635
The mitogen-activated protein (MAP) cascade leading to the activation of extracellular signal-regulated kinases 1/2 (ERK1/2) is critical for regulating myeloma cell growth; however, the relationship of ERK1/2 activity with vascular endothelial growth
Autor:
Teodoro Chisesi, Magda Hojden, Nicola Giuliani, Mirija Svaldi, Mirca Lazzaretti, Simona Colla, Sabrina Bonomini, Vittorio Rizzoli, Paola Polistena, P. Coser, Francesca Morandi, Eugenia Martella
Publikováno v:
Blood. 102:3071-3073
Basic fibroblast growth factor (bFGF) is a growth factor with proangiogenetic properties. Elevated bone marrow (BM) and peripheral serum bFGF levels have been reported in patients with multiple myeloma (MM)[1][1]-[3][2]; however, the source of bFGF i
Autor:
B S Giovanni Raciti, Giovanni Battista Del Giudice, Francesca Morandi, Patrizia Pepi, Oliveir Bizeau, Domenico Pecora, Serafino Orazi, Alberto Scaccia, Mattia Liccardo, Salvatore Ivan Caico, Olivier Citerne
Publikováno v:
Pacing and clinical electrophysiology : PACE. 31(12)
Background: The optimalprogramming of a pacemaker (PM) voltage output considers both efficiency (prolonging battery cell longevity) and patient safety (adequate safety margin). Currently, automatic capture (AC) algorithms are designed to ensure safe